Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Nashville,, TN
SEC filing record 1 source field available
Fiscal year end
31 December
CUMBERLAND PHARMACEUTICALS INC has filed 1,032 SEC EDGAR filings since 02 May 2002

SEC filing history

Showing 551-575 of 959 matching filings.

Per page
25
Current page
23
8-K File 001-33637

8-K 2018 GEL AGREEMENT

Filing date
16 Mar 2018
Reporting date
16 Mar 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
DEF 14A File 001-33637

DEF 14A 2018 PROXY STATEMENT

Filing date
15 Mar 2018
Reporting date
24 Apr 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
DEFA14A File 001-33637

DEFA14A 2018 ADDITIONAL DEFINITIVE PROXY MATERIALS

Filing date
15 Mar 2018
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-33637

8-K 2017 EARNINGS RELEASE

Filing date
09 Mar 2018
Reporting date
09 Mar 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-85205

SC 13G/A filing

Filing date
13 Feb 2018
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-85205

SC13GA CUMBERLAND PHARM DEC17

Filing date
13 Feb 2018
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G File 005-85205

SC 13G - AJ KAZIMI 2017

Filing date
09 Feb 2018
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-85205

SCHEDULE 13G/A

Filing date
09 Feb 2018
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-33637

8-K - AMIFOSTINE STUDY

Filing date
02 Feb 2018
Reporting date
02 Feb 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
EFFECT File 333-221402

EFFECT filing

Filing date
16 Jan 2018
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
CORRESP

CORRESP filing

Filing date
11 Jan 2018
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
S-3/A File 333-221402

FORM S-3/A

Filing date
09 Jan 2018
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
CORRESP

CORRESP filing

Filing date
29 Dec 2017
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
22 Dec 2017
Reporting date
22 Dec 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
S-3/A File 333-221402

FORM S-3/A

Filing date
19 Dec 2017
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
CORRESP

CORRESP filing

Filing date
18 Dec 2017
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-33637

8-K - INVESTOR PRESENTATION DEC. 2017

Filing date
08 Dec 2017
Reporting date
08 Dec 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
24 Nov 2017
Reporting date
20 Nov 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
24 Nov 2017
Reporting date
22 Nov 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
UPLOAD

UPLOAD filing

Filing date
17 Nov 2017
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
10-Q File 001-33637

10-Q Q3 2017

Filing date
08 Nov 2017
Reporting date
30 Sep 2017
Next action
Verify source filing
8-K File 001-33637

8-K - Q3 2017 EARNINGS RELEASE

Filing date
08 Nov 2017
Reporting date
08 Nov 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
S-3 File 333-221402

FORM S-3

Filing date
07 Nov 2017
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-33637

8-K - TOTECT LAUNCH

Filing date
29 Sep 2017
Reporting date
29 Sep 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .